David V. Schaffer
Impact in
- Developmental Neuroscience top 0.2%
- Neurogenesis and neuroplasticity mechanisms
- Molecular Biology top 0.2%
- CRISPR and Genetic Engineering
- RNA Interference and Gene Delivery
- Pluripotent Stem Cells Research
- Retinal Development and Disorders
Papers in
-
- RNA Interference and Gene Delivery 60
- CRISPR and Genetic Engineering 57
- Pluripotent Stem Cells Research 50
- Viral Infectious Diseases and Gene Expression in Insects 31
- Genetics 98
- Virus-based gene therapy research 89
- Co-authors
- Melissa A. Kotterman (6 shared papers)Brian K. Kaspar (8 shared papers)John G. Flannery (26 shared papers)Kevin E. Healy (21 shared papers)James T. Koerber (13 shared papers)Ravi S. Kane (22 shared papers)Krishanu Saha (7 shared papers)Deniz Dalkara (17 shared papers)
- Journals
- Molecular Therapy (22 papers)Gene Therapy (9 papers)Proceedings of the National Academy of Sciences (8 papers)Biotechnology and Bioengineering (8 papers)Biomaterials (8 papers)
- Partner nations
- United StatesSouth KoreaRussia
In The Last Decade
David V. Schaffer
285 papers receiving 21.9k citations
David V. Schaffer's Hit Papers
Peers
Comparison fields: 5 of 180
- Developmental Neuroscience 1.4k
- Molecular Biology 13.5k
- Cellular and Molecular Neuroscience 3.5k
- Genetics 5.3k
- Virology 653
Countries citing papers authored by David V. Schaffer
This map shows the geographic impact of David V. Schaffer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David V. Schaffer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David V. Schaffer more than expected).
Fields of papers citing papers by David V. Schaffer
This network shows the impact of papers produced by David V. Schaffer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David V. Schaffer. The network helps show where David V. Schaffer may publish in the future.
Co-authors
The 25 scholars most cited alongside David V. Schaffer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 294 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Substrate Modulus Directs Neural Stem Cell Behavior Hit paper breakdown → | 2008 | 922 |
| 2 | A Designer AAV Variant Permits Efficient Retrograde Access to Projection Neurons Hit paper breakdown → | 2016 | 868 |
| 3 | Sonic hedgehog regulates adult neural progenitor proliferation in vitro and in vivo Hit paper breakdown → | 2002 | 678 |
| 4 | Engineering adeno-associated viruses for clinical gene therapy Hit paper breakdown → | 2014 | 637 |
| 5 | The influence of hydrogel modulus on the proliferation and differentiation of encapsulated neural stem cells Hit paper breakdown → | 2009 | 589 |
| 6 | In Vivo–Directed Evolution of a New Adeno-Associated Virus for Therapeutic Outer Retinal Gene Delivery from the Vitreous Hit paper breakdown → | 2013 | 584 |
| 7 | Stochastic Gene Expression in a Lentiviral Positive-Feedback Loop: HIV-1 Tat Fluctuations Drive Phenotypic Diversity Hit paper breakdown → | 2005 | 502 |
| 8 | 2000 | 463 | |
| 9 | 2006 | 446 | |
| 10 | Biophysical regulation of epigenetic state and cell reprogramming Hit paper breakdown → | 2013 | 409 |
| 11 | 2007 | 386 | |
| 12 | Viral Vectors for Gene Therapy: Translational and Clinical Outlook Hit paper breakdown → | 2015 | 381 |
| 13 | The AAV Vector Toolkit: Poised at the Clinical Crossroads Hit paper breakdown → | 2012 | 381 |
| 14 | 2013 | 366 | |
| 15 | 2014 | 348 | |
| 16 | 2009 | 282 | |
| 17 | 2014 | 278 | |
| 18 | 2013 | 277 | |
| 19 | 2015 | 270 | |
| 20 | 2012 | 264 |
About David V. Schaffer
David V. Schaffer is a scholar working on Molecular Biology, Genetics, Biomedical Engineering, Cellular and Molecular Neuroscience and Cell Biology, having authored 294 papers that have together received 22.3k indexed citations. Recurring topics across this work include Virus-based gene therapy research (89 papers), RNA Interference and Gene Delivery (60 papers), CRISPR and Genetic Engineering (57 papers), Pluripotent Stem Cells Research (50 papers), 3D Printing in Biomedical Research (48 papers), Cellular Mechanics and Interactions (34 papers), Neurogenesis and neuroplasticity mechanisms (32 papers) and Viral Infectious Diseases and Gene Expression in Insects (31 papers). The work is most often cited by research in Developmental Neuroscience (1.4k citations), Molecular Biology (13.5k citations), Cellular and Molecular Neuroscience (3.5k citations), Genetics (5.3k citations) and Virology (653 citations). David V. Schaffer has collaborated with scholars based in United States, South Korea and Russia. Frequent co-authors include Melissa A. Kotterman, Brian K. Kaspar, John G. Flannery, Kevin E. Healy, James T. Koerber, Ravi S. Kane, Krishanu Saha, Deniz Dalkara, Albert J. Keung and Adam P. Arkin. Their work appears in journals such as Molecular Therapy, Gene Therapy, Proceedings of the National Academy of Sciences, Biotechnology and Bioengineering and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.